نبذة مختصرة : Background : pulmonary rehabilitation (PR) is one of the key treatments for patients with chronic obstructive pulmonary disease (COPD). Its benefits have been widely proved in terms of dyspnea, quality of life, level of physical activity and reduction in hospital admissions. Sustaining gains is a major issue after a PR program, but the assessment tools are few. Objective: to assess the proportion of patients maintaining their personal goals after a PR program. Method: our multicenter prospective observational study included patients with COPD after a standard PR program for a one-year follow-up with reassessment at 6 and 12 months. The main criterion was the proportion of patients maintaining at least half of their goals at 6 and 12 months. Results: we had preliminary data from the first 45 patients out of 220 expected, with a proportion of 78% patients maintaining at least half of their goals at 6 months and a goals retention rate of 64% at 6 months. There is no statistically significant difference at six months in the scores of dyspnea (dyspnea12, LCADL), anxiety and depression (HAD), self-esteem (IPS-6) despite a statistically significant decrease in exercise capacity (TM6 and muscular endurance). Conclusion: the preliminary results show that more than half of their projects were maintained in 78% of patients, with a goals retention rate of 64% at six months. Writing project(s) with regular monitoring of patients seems to promote the achievement of personal goals after a PR program. Evaluating the maintenance of personal goals may become a new tool for measuring sustaining gains after a PR program. ; Contexte : la réadaptation respiratoire (RR) est un traitement clé des patients atteints de broncho-pneumopathie chronique obstructive (BPCO). Ses bénéfices sont démontrés concernant la dyspnée, la qualité de vie, le niveau d’activité physique et la réduction des hospitalisations. Le maintien des acquis est un enjeu majeur après un programme de RR mais les outils pour l’évaluer sont peu nombreux.Objectif : ...
No Comments.